Skip to main content
SpringerLink
Log in

Interpreting differences in quality of life: The FACT-H&N in laryngeal cancer patients

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Quality of life (QOL) scores can be difficult to interpret, because small statistically significant differences can be clinically unimportant. Our goal was to estimate the magnitude of difference in QOL that is noticeable to patients. Methods: Laryngeal cancer patients (n = 98, male = 83%, mean age = 65) completed a QOL questionnaire, FACT-H&N. Paired participants rated their own QOL as compared to each other. We estimated the smallest difference in QOL score that was associated with a noticeable difference in patients' subjective ratings. Results: Differences in FACT-H&N score were somewhat correlated with patients' ratings of their well-being relative to other patients (r= 0.195, p < 0.0001). The FACT-H&N score had to differ by 6.22 for patients to rate themselves as ‘a little bit better’ relative to other patients (95% CI: 1.42–11.02), and by 12.40 for patients to rate themselves as ‘a little bit worse’ relative to others (95% CI: 5.09–19.71). Results were consistent regardless of patient age, gender or laryngeal subsite but were imperfect predictors of individual judgements. Conclusion: The minimal important difference for the FACT-H&N score is about 6–12 units, but laryngeal cancer survivors may be more sensitive to gains than losses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. National Cancer Institute of Canada. Canadian Cancer Statistics 1997. National Cancer Institute of Canada, 1997.

  2. Sobin LH, Wittekind Ch, eds. International Union Against Cancer TNM Classification of Malignant Tumours. 5th ed. New York: John Wiley & Sons, 1997: 33-37.

    Google Scholar 

  3. Finizia C, Geterud A, Holmberg E, et al. Advanced laryngeal cancer T3-T4 in Sweden: A retrospective study (1986–1990) — survival and locoregional control related to treatment. Acta Otolaryngol (Stockh) 1996; 116: 906-912.

    Google Scholar 

  4. Forestiere AA, Berkey B, Maor M, et al. Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R91-11 [abst]. Proc Am Soc Clin Oncol (ASCO), San Francisco; J Clin Oncol 2001; 20: 2a.

    Google Scholar 

  5. The Department of Veterans' Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1690.

    Google Scholar 

  6. Guyatt GH, Feeny D, Patrick D. Proceedings of the international conference on the measurement of quality of life as an outcome in clinical trials: Postscript. Controlled Clin Trials 1991; 12: 266S-269S.

    Google Scholar 

  7. Liang MH. Evaluating measurement responsiveness. J Rheumatol 1995; 22: 1191-1192.

    Google Scholar 

  8. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res 1993; 2: 221-226.

    Google Scholar 

  9. Jaeschke R, Singer J, Guyatt GH. Measurement of Health Status: Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415.

    Google Scholar 

  10. Wright JG. The minimal important difference: Who's to say what is important? J Clin Epidemiol 1996; 49: 1221-1222.

    Google Scholar 

  11. Ringash J, Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck 2001; 23: 201-213.

    Google Scholar 

  12. D'Antonio LL, Zimmerman GJ, Cella DF, et al. Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1996; 122: 482-487.

    Google Scholar 

  13. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 1993; 11(3): 570-579.

    Google Scholar 

  14. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM (ed.), Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949: 191-205.

    Google Scholar 

  15. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol 1996; 49: 1215-1219.

    Google Scholar 

  16. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-87.

    Google Scholar 

  17. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-144.

    Google Scholar 

  18. Redelmeier DA, Lorig K. Assessing the clinical importance of symptomatic improvements: An illustration in rheumatology. Arch Intern Med 1993; 153: 1337-1342.

    Google Scholar 

  19. Wells GA, Tugwell P, Kraag GR, et al. Minimum important difference between patients with rheumatoid arthritis: The patient's perspective. J Rheumatol 1993; 20: 557-560.

    Google Scholar 

  20. Redelmeier DA, Goldstein RS, Min ST, et al. Spirometry and dyspnea in patients with COPD: when small differences mean little. Chest 1996; 109: 1163-1168.

    Google Scholar 

  21. Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: The six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282.

    Google Scholar 

  22. Moses LE. Think and Explain with Statistics. Reading, Massachusetts: Addison Wesley 1986: 336-338.

    Google Scholar 

  23. Ringash J, Redelmeier D, O'Sullivan B, Bezjak A. Quality of life and utility in irradiated laryngeal cancer patients. Int J Rad Onc Biol Phys 2000; 47: 875-881.

    Google Scholar 

  24. List MA, D'Antonio LL, Cella DF, et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy — Head and Neck scale. Cancer 1996; 77: 2294-2301.

    Google Scholar 

  25. Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Qual Life Res 2002; 11: 207-221.

    Google Scholar 

  26. Cella DF. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales. Centre on Outcomes, Research and Education (CORE), Evanston: Northwestern Healthcare and Northwestern University, 1997.

    Google Scholar 

  27. Brant R, Sutherland L, Hilsden R. Examing the minimum important difference. Stat Med 1999; 18: 2593-2603.

    Google Scholar 

  28. Weinstein ND. Optimistic biases about personal risks. Science 1989; 246: 1232-1233.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada

    Jolie Ringash, Andrea Bezjak & Brian O'Sullivan

  2. Sunnybrook & Women's Hospital and the Institute for Clinical Evaluative Sciences, Toronto, ON, Canada

    Donald A. Redelmeier

  3. University of Toronto, Toronto, ON, Canada

    Jolie Ringash, Andrea Bezjak, Brian O'Sullivan & Donald A. Redelmeier

Authors
  1. Jolie Ringash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Bezjak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian O'Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Donald A. Redelmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ringash, J., Bezjak, A., O'Sullivan, B. et al. Interpreting differences in quality of life: The FACT-H&N in laryngeal cancer patients. Qual Life Res 13, 725–733 (2004). https://doi.org/10.1023/B:QURE.0000021703.47079.46

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:QURE.0000021703.47079.46

Search

Navigation